A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
- Status
- COMPLETED
- Phase
- NA
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Trastuzumab and Vinorelbine in Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2